Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

NCT03381859 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped HCV treatment expansion occurred in Egypt

Conditions

Hepatitis C Virus Infection, Response to Therapy of

Interventions

DRUG: Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]